PubMed

Reliability of Lightguide Spectrophotometry (O2C) for the Investigation of Skin Tissue Microvascular Blood Flow and Tissue Oxygen Supply in Diabetic and Nondiabetic Subjects.

Forst T, Hohberg C, Tarakci E, Forst S, Kann P, Pfützner A.

J Diabetes Sci Technol. 2008 Nov;2(6):1151-6.PMID: 19885305 [PubMed - in process]Free article

Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the FlexPen device.

Forst T, Hohberg C, Schöndorf T, Borchert M, Forst S, Roth W, Dehos B, Pfützner A.

Diabetes Technol Ther. 2009 Feb;11(2):87-92.PMID: 19848574 [PubMed - in process]Related articles

Postprandial Vascular Effects of ViajectTM compared with Insulin Lispro and Regular Human Insulin in Patients with Type 2 Diabetes Mellitus.

Forst T, Pfützner A, Flacke F, Krasner A, Hohberg C, Tarakci E, Pichotta P, Forst S, Steiner S.

Diabetes Care. 2009 Oct 6. [Epub ahead of print]PMID: 19808913 [PubMed - as supplied by publisher]Related articles

Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual beta-cell function: results from the PioSwitch study.

Hohberg C, Pfützner A, Forst T, Lübben G, Karagiannis E, Borchert M, Schöndorf T.

Diabetes Obes Metab. 2009 May;11(5):464-71.PMID: 19422402 [PubMed - in process]Related articles

Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients.

Forst T, Hohberg C, Pfützner A.

Horm Metab Res. 2009 Feb;41(2):123-31. Epub 2009 Feb 12. Review.PMID: 19214922 [PubMed - indexed for MEDLINE]Related articles

Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.

Reimer T, Hohberg C, Pfützner AH, Jørgensen C, Jensen KH, Pfützner A.

Clin Ther. 2008 Dec;30(12):2252-62.PMID: 19167585 [PubMed - indexed for MEDLINE]Related articles

Prefilled insulin device with reduced injection force: patient perception and accuracy.

Pfützner A, Reimer T, Hohberg C, Frøkjaer LP, Jørgensen C.

Curr Med Res Opin. 2008 Sep;24(9):2545-9. Epub 2008 Jul 31.PMID: 18674410 [PubMed - indexed for MEDLINE]Related articles

Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state.

Hohberg C, Forst T, Larbig M, Safinowski M, Diessel S, Hehenwarter S, Weber MM, Schöndorf T, Pfützner A.

Diabetes Care. 2008 May;31(5):1021-5. Epub 2008 Feb 11.PMID: 18268067 [PubMed - indexed for MEDLINE]Related articlesFree article

Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study.

Pfützner A, Hanefeld M, Lübben G, Weber MM, Karagiannis E, Köhler C, Hohberg C, Forst T.

Horm Metab Res. 2007 Oct;39(10):764-8.PMID: 17952841 [PubMed - indexed for MEDLINE]Related articles

Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitus.

Schöndorf T, Lübben G, Hoopmann M, Borchert M, Forst T, Hohberg C, Löbig M, Armbruster FP, Roth W, Grabellus M, Pfützner A.

Gynecol Endocrinol. 2007 Jun;23(6):356-60.PMID: 17616862 [PubMed - indexed for MEDLINE]Related articles

Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease.

Forst T, Karagiannis E, Lübben G, Hohberg C, Schöndorf T, Dikta G, Drexler M, Morcos M, Dänschel W, Borchert M, Pfützner A.

Atherosclerosis. 2008 Mar;197(1):311-7. Epub 2007 Jun 22.PMID: 17588584 [PubMed - indexed for MEDLINE]Related articles

Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitus.

Schöndorf T, Forst T, Hohberg C, Lübben G, Armbruster FP, Roth W, Borchert M, Köder C, Löbig M, Grabellus M, Pfützner A.

Clin Lab. 2007;53(3-4):193-8.PMID: 17447657 [PubMed - indexed for MEDLINE]Related articles

Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.

Forst T, Pfützner A, Lübben G, Weber M, Marx N, Karagiannis E, Koehler C, Baurecht W, Hohberg C, Hanefeld M.

Metabolism. 2007 Apr;56(4):491-6.PMID: 17379006 [PubMed - indexed for MEDLINE]Related articles

The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight.

Schöndorf T, Forst T, Hohberg C, Pahler S, Link C, Roth W, Pfützner A, Lübben G, Link C, Pfützner A.

Diabetes Obes Metab. 2007 Jan;9(1):132-3. No abstract available. PMID: 17199730 [PubMed - indexed for MEDLINE]Related articles

Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus.

Pfützner A, Standl E, Strotmann HJ, Schulze J, Hohberg C, Lübben G, Pahler S, Schöndorf T, Forst T.

Clin Chem Lab Med. 2006;44(5):556-60.PMID: 16681424 [PubMed - indexed for MEDLINE]Related articles

Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2.

Forst T, Lübben G, Hohberg C, Kann P, Sachara C, Gottschall V, Friedrich C, Rosskopf R, Pfützner A.

Microcirculation. 2005 Oct-Nov;12(7):543-50.PMID: 16207627 [PubMed - indexed for MEDLINE]Related articles

Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetes.

Forst T, Hohberg C, Fuellert SD, Lübben G, Konrad T, Löbig M, Weber MM, Sachara C, Gottschall V, Pfützner A.

Horm Metab Res. 2005 Aug;37(8):521-7.PMID: 16138267 [PubMed - indexed for MEDLINE]Related articles

Pioneer study: PPARgamma activation results in overall improvement of clinical and metabolic markers associated with insulin resistance independent of long-term glucose control.

Pfützner A, Hohberg C, Lübben G, Pahler S, Pfützner AH, Kann P, Forst T.

Horm Metab Res. 2005 Aug;37(8):510-5.PMID: 16138265 [PubMed - indexed for MEDLINE]Related articles

IRIS II study: intact proinsulin is confirmed as a highly specific indicator for insulin resistance in a large cross-sectional study design.

Pfützner A, Standl E, Hohberg C, Konrad T, Strotmann HJ, Lübben G, Langenfeld MR, Schulze J, Forst T.

Diabetes Technol Ther. 2005 Jun;7(3):478-86.PMID: 15929679 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study.

Langenfeld MR, Forst T, Hohberg C, Kann P, Lübben G, Konrad T, Füllert SD, Sachara C, Pfützner A.

Circulation. 2005 May 17;111(19):2525-31. Epub 2005 May 9.PMID: 15883215 [PubMed - indexed for MEDLINE]Related articlesFree article

IRIS II study: the IRIS II score--assessment of a new clinical algorithm for the classification of insulin resistance in patients with Type 2 diabetes.

Forst T, Standl E, Hohberg C, Konrad T, Schulze J, Strotmann HJ, Lübben G, Pahler S, Bachinger A, Langenfeld M, Pfützner A.

Diabet Med. 2004 Oct;21(10):1149-53.PMID: 15384965 [PubMed - indexed for MEDLINE]Related articles

Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.

Pfützner A, Kunt T, Hohberg C, Mondok A, Pahler S, Konrad T, Lübben G, Forst T.

Diabetes Care. 2004 Mar;27(3):682-7.PMID: 14988285 [PubMed - indexed for MEDLINE]Related articlesFree article